Monday, 28 May 2018

Drug Safety

Datesort ascending Type Title Save
19 Dec 2017 Social High Costs of FDA Approval for Formerly Unapproved Marketed Drugs #medicine #feedly https://t.co/502dMIJ4wu
18 Dec 2017 News Baseline Risk Score Predicts Serious Infection Risk in TNF-Treated RA Patients
18 Dec 2017 News Advantages of Intravenous Pulse Cyclophosphamide in ANCA-associated Vasculitis
17 Dec 2017 Social Sanofi recalls SYNVISC-One, specifically one batch of ~12,000 plus distributed between Oct. 25 -Nov. 7, 2017 only in the USA https://t.co/3f4ocIoEEl
17 Dec 2017 Social RT @TaraCortes: An Overlooked Epidemic: Older Americans Taking Too Many Unneeded Drugs https://t.co/n82hkTdO3V via @khnews
16 Dec 2017 Social RheumNow Wk in Review is Up! Cush reviews UK GCA turndown, FUO Dx by FDG-PET, Novel ABA results, Sjogrens STAT3 story. https://t.co/FCUQ9lCSvo https://t.co/fR7Zf3b7UG
14 Dec 2017 Social NICE and NHS reject the approval of Tocilizumab for use in GCA citing cost concerns https://t.co/TZMmnj91sp https://t.co/aQMFLKVCYo
12 Dec 2017 Social RT @StefanSiebert1: JAK inhibitors and thrombotic events - especially pulmonary. Review of FDA safety data https://t.co/yZgYfzOwV1 with exc…
08 Dec 2017 Social RT @FDA_Drug_Info: #FDA again approved more generics in a single month than ever before, 107 in Nov. 2017, improving access to affordable d…
05 Dec 2017 Social FDA grants orphan drug designation to SER-287 a microbiome drug to treat dysbiosis of pediatric ulcerative colitis. Will microbiome targeted therapies be the next (safe) best thing? https://t.co/PmOLeyLyy3
01 Dec 2017 Social Taltz (ixekizumab), the IL-17 inhibitor from Lilly, is FDA Approved for use in Active Psoriatic Arthritis, based on… https://t.co/dY4tQNqfcC
29 Nov 2017 Social FDA approves Fasenra (benralizumab) that binds to the IL-5α receptor, and depletes eosinophils rapidly. Indicated… https://t.co/2CD3qhAzvO
27 Nov 2017 Social RT @FDA_Drug_Info: Learn about The FDA’s Sentinel Initiative in the latest CDER Conversation: https://t.co/cWaa00bTFZ. https://t.co/MJRBpVr…
27 Nov 2017 Social FDA approved rheumatology drugs in 2017: Brodalumab (Siliq); oral Methotrexate solution (Xatmep): Abaloparatide (Ty… https://t.co/CWToiMvidA
27 Nov 2017 Social FDA advisory panel votes 22-1 against a new abuse deterant Oxycontin ER (named Rexista) from Intellipharmaceutics,… https://t.co/50FfXPC1vG
20 Nov 2017 Blog Creaky Joints Nails New Patient Pregnancy and Family Planning Guidelines
19 Nov 2017 Social RT @conradhackett: The devastating spread of opioid overdose deaths https://t.co/BbakgXkUl9
19 Nov 2017 Social RheumNow Week in Review is up! Watch on https://t.co/o6Mv4n9vQp or subscribe to the podcase on iTunes or here https://t.co/r4ndrsHSSl
17 Nov 2017 News J&J Hit with a $247 Million Verdict over Metal-on-Metal Hip Replacements
15 Nov 2017 Social FDA issues a Safety Alert over FEBUXOSTAT and increased risk of Cardiac Death (compared to allopurinol users). This… https://t.co/3clsintj7L